These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12821544)

  • 1. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.
    Sauer WH; Berlin JA; Kimmel SE
    Circulation; 2003 Jul; 108(1):32-6. PubMed ID: 12821544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors and myocardial infarction.
    Sauer WH; Berlin JA; Kimmel SE
    Circulation; 2001 Oct; 104(16):1894-8. PubMed ID: 11602490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
    J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
    Schlienger RG; Fischer LM; Jick H; Meier CR
    Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study.
    Noordam R; Aarts N; Leening MJ; Tiemeier H; Franco OH; Hofman A; Stricker BH; Visser LE
    Eur J Clin Pharmacol; 2016 Feb; 72(2):211-8. PubMed ID: 26546336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
    Meier CR; Schlienger RG; Jick H
    Br J Clin Pharmacol; 2001 Aug; 52(2):179-84. PubMed ID: 11488775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.
    Scheffel U; Kim S; Cline EJ; Kuhar MJ
    Synapse; 1994 Apr; 16(4):263-8. PubMed ID: 8059336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.
    Mortensen OV; Kristensen AS; Wiborg O
    J Neurochem; 2001 Oct; 79(2):237-47. PubMed ID: 11677251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.
    Douros A; Dell'Aniello S; Dehghan G; Boivin JF; Renoux C
    Neurology; 2019 Sep; 93(10):e1010-e1020. PubMed ID: 31391245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
    Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
    Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
    Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin transporter from human brain: purification and partial characterization.
    Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
    Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002.
    Benazon NR; Mamdani MM; Coyne JC
    Psychosom Med; 2005; 67(6):916-20. PubMed ID: 16314596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.
    Tata LJ; West J; Smith C; Farrington P; Card T; Smeeth L; Hubbard R
    Heart; 2005 Apr; 91(4):465-71. PubMed ID: 15772201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.
    Taylor CB; Youngblood ME; Catellier D; Veith RC; Carney RM; Burg MM; Kaufmann PG; Shuster J; Mellman T; Blumenthal JA; Krishnan R; Jaffe AS;
    Arch Gen Psychiatry; 2005 Jul; 62(7):792-8. PubMed ID: 15997021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.